Quipt Home Medical Corp. (QIPT)
USD 2.41
(-7.49%)
USD 2.41
(-7.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 40.53 Million | 26.34 Million | 18.69 Million | 13.17 Million | 8.39 Million | 10.64 Million |
| Net Income | -2.78 Million | 4.83 Million | -6.17 Million | -5.04 Million | -5.57 Million | -5.39 Million |
| Depreciation & Amortization | 39.86 Million | 23.04 Million | 17.78 Million | 14.61 Million | 10.55 Million | 12.02 Million |
| Deferred income taxes | 85 Thousand | -1.9 Million | -3.8 Million | 6.6 Million | 4.29 Million | 4.05 Million |
| Stock-based compensation | 5.28 Million | 5.49 Million | 4.95 Million | 171 Thousand | 1.55 Million | 1.29 Million |
| Change in working capital | -1.94 Million | 758 Thousand | -8.87 Million | -4.66 Million | -3.82 Million | -4.37 Million |
| Other non-cash items | 34.27 Thousand | -5.88 Million | 14.8 Million | 1.48 Million | 1.38 Million | 3.04 Million |
| Investing Cash Flow | -82.82 Million | -42.49 Million | -17.83 Million | -7.89 Million | 1.76 Million | -723.67 Thousand |
| Investments in PPE | -6.78 Million | -8.96 Million | -5.04 Million | -91.88 Thousand | -1.36 Million | -530.18 Thousand |
| Acquisitions | -76.03 Million | -33.52 Million | -12.89 Million | -8.05 Million | 2.96 Million | -422.59 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 88.28 Thousand | 266.56 Thousand | 98 Thousand | 254 Thousand | 161.65 Thousand | 229.1 Thousand |
| Financing Cash Flow | 50.87 Million | -9.85 Million | 3.91 Million | 13.95 Million | -3.82 Million | -10.51 Million |
| Debt repayment | -39.55 Million | -20.63 Million | -13.89 Million | -13.04 Million | -16.86 Million | -8.42 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.32 Million | - | - | - | - | - |
| Common Stock Issuance | 27.01 Million | 523.47 Thousand | 19.01 Million | 19.44 Million | 3.13 Million | - |
| Other Financing Activities | 66.07 Million | 10.26 Million | -1.2 Million | 7.54 Million | 9.9 Million | -2.08 Million |
| Accounts receivables | -3.04 Million | -201 Thousand | -8.82 Million | -5.14 Million | -5.16 Million | -6.99 Million |
| Accounts payables | 3.14 Million | 2.67 Million | 518 Thousand | 2.2 Million | 938.82 Thousand | -4.11 Million |
| Inventory | -59.56 Thousand | -2.41 Million | -44 Thousand | -1.77 Million | 637.55 Thousand | 3.69 Million |
| Other working capital | -1.99 Million | 703.38 Thousand | -525 Thousand | 46.31 Thousand | -237.8 Thousand | 3.04 Million |
| Cash at beginning of period | 8.51 Million | 34.61 Million | 29.22 Million | 9.6 Million | 3.27 Million | 2.62 Million |
| Cash at end of period | 17.2 Million | 8.51 Million | 34.61 Million | 29.12 Million | 9.71 Million | 3.35 Million |
| Capital Expenditure | -6.78 Million | -8.96 Million | -5.04 Million | -91.88 Thousand | -1.36 Million | -530.18 Thousand |
| Effect of forex changes on cash | 108 Thousand | -96 Thousand | 621 Thousand | 293.59 Thousand | 104.24 Thousand | 1.31 Million |
| Net cash flow / Change in cash | 8.69 Million | -26.09 Million | 5.38 Million | 19.52 Million | 6.43 Million | 727.54 Thousand |
| Free Cash Flow | 33.74 Million | 17.37 Million | 13.64 Million | 13.07 Million | 7.02 Million | 10.11 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.7 Million | -1.35 Million | -602.19 Thousand | -2.78 Million | -1.32 Million | -1.03 Million |
| Depreciation & Amortization | 12.45 Million | 11.91 Million | 12.68 Million | 39.86 Million | 11.93 Million | 11.69 Million |
| Deferred income taxes | 61.57 Thousand | 263 Thousand | 220 Thousand | 85 Thousand | 75 Thousand | -323 Thousand |
| Stock-based compensation | 483 Thousand | 701 Thousand | 970 Thousand | 5.28 Million | 1.36 Million | 2.03 Million |
| Change in working capital | 335.65 Thousand | -5.94 Million | -911.51 Thousand | -1.94 Million | 1.07 Million | 139 Thousand |
| Other non-cash items | 22.77 Million | 30.13 Million | -305.2 Thousand | 34.27 Thousand | 93.55 Thousand | -17 Thousand |
| Investing Cash Flow | -4.1 Million | -1.18 Million | -1.67 Million | -82.82 Million | -6.08 Million | 856 Thousand |
| Investments in PPE | -4.07 Million | -1.17 Million | -1.61 Million | -6.78 Million | -1.82 Million | -22 Thousand |
| Acquisitions | -28.99 Thousand | -6699.04 | -63.71 Thousand | -76.03 Million | -4.16 Million | 820 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 57 Thousand | -9482.00 | -1.00 | 88.28 Thousand | -84 Thousand | 58 Thousand |
| Financing Cash Flow | -7.41 Million | -7.61 Million | -9.54 Million | 50.87 Million | -10.05 Million | 4.56 Million |
| Debt repayment | -6.49 Million | -5.98 Million | -8.02 Million | -39.55 Million | -14.91 Million | -15.13 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -588.63 | -213.11 Thousand | - | -1.32 Million | 610.15 | 5926.00 |
| Common Stock Issuance | 564.09 Thousand | - | - | 27.01 Million | -854 Thousand | 28.68 Million |
| Other Financing Activities | -203 Thousand | -226 Thousand | -1.51 Million | 66.07 Million | 5.71 Million | 19.7 Million |
| Accounts receivables | 1.14 Million | -8.61 Million | 2.04 Million | -3.04 Million | -1.15 Million | 1.35 Million |
| Accounts payables | 1.5 Million | 5.75 Million | -1.83 Million | 3.14 Million | 632.18 Thousand | -1.46 Million |
| Inventory | -165.07 Thousand | -2.72 Million | -1.33 Million | -59.56 Thousand | 2.39 Million | 518 Thousand |
| Other working capital | -2.14 Million | -364.2 Thousand | 212.72 Thousand | -1.99 Million | -801.06 Thousand | -265 Thousand |
| Cash at beginning of period | 14.58 Million | 18.23 Million | 17.12 Million | 8.51 Million | 20.44 Million | 2.08 Million |
| Cash at end of period | 14.4 Million | 14.58 Million | 18.23 Million | 17.2 Million | 17.2 Million | 20.44 Million |
| Capital Expenditure | -4.07 Million | -1.17 Million | -1.61 Million | -6.78 Million | -1.82 Million | -22 Thousand |
| Effect of forex changes on cash | -183 Thousand | -264 Thousand | 302 Thousand | 108 Thousand | -322 Thousand | 441 Thousand |
| Net cash flow / Change in cash | -188.05 Thousand | -3.64 Million | 1.1 Million | 8.69 Million | -3.23 Million | 18.35 Million |
| Free Cash Flow | 7.41 Million | 4.15 Million | 10.44 Million | 33.74 Million | 11.39 Million | 12.47 Million |
0542
214320
APGN
CAR
APX
MED